- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
AstraZeneca Pharma India Limited — Important, 06-08-2025: Updates
06-08-2025 | 02:59 pm
06-08-2025 | 02:59 pm
AstraZeneca Pharma India Limited is set to launch Eculizumab (Soliris) in India in August 2025. This specialized drug, indicated for Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic Uremic Syndrome (aHUS), expands the company's product portfolio after securing necessary market approvals. This strategic launch is a significant business development, poised to address unmet medical needs and contribute to the company's future revenue streams. A key watch for investors.
No comments yet. Be the first to comment!